Recruiting
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
NCT05475925
- Conditions
- Aggressive NK Cell Leukemia, Cutaneous PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), +27 more
- Locations
-
- Dren Investigational Site Birmingham, Alabama, United States
- Dren Investigational Site Duarte, California, United States
- Dren Investigational Site Irvine, California, United States
- Dren Investigational Site Redwood City, California, United States